At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Sep 9, 2026 at 16:17 ET
Two top executives at Relay Therapeutics, CEO Sanjiv Patel and President of R&D Donald Bergstrom, sold a combined $1.07M in open-market sales on September 8, 2026. While the dollar amount is modest relative to the $4.2B market cap (~0.03%), the cluster involves the CEO and President of R&D selling on the same day, which warrants attention. The stock has a 95% analyst buy rating and strong institutional support, but the insider sales introduce a note of caution against the bullish consensus.
- CEO Sanjiv Patel sold 48,199 shares at $18.94 for $912,889 on September 8, 2026.
- President of R&D Donald Bergstrom sold 8,530 shares at $18.97 for $161,814 on September 8, 2026.
- CFO Thomas Catinazzo also sold 17,717 shares at $18.94 for $335,560 on September 8, 2026.
- Total cluster value is $1.07M, representing approximately 0.03% of the $4.2B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access